Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this project is to realize a randomized open-label study (EudraCT number: 2020-000120-19) to evaluate the safety and the anti-tumor activity of peptide(s)-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous cell carcinoma of the head and neck.
Epistemonikos ID: e8a15292d12f553e67cc81fadca497d213024377
First added on: May 07, 2024